John P. Sfakianos, MD, discusses the challenges of managing recurrent LG-IR-NMIBC and the role of chemoablation.
Beyond TURBT: Evolving Strategies in LG-IR-NMIBC
Sandip Prasad, MD, MPhil, discusses the evolving role of chemoablation in recurrent low-grade, intermediate-risk NMIBC, including patient selection and treatment considerations.
Sandip Prasad, MD, discusses patient selection for chemoablation in recurrent LG-IR-NMIBC and considerations when counseling patients about a nonsurgical approach.
Advertisement
Advertisement
Trending on Urology Times
1
SBRT, prostatectomy show comparable long-term disease control in PACE-A trial
2
Pivotal trial launches of GRPR-targeted PET imaging agent in prostate cancer
3
A rising tide that lifts all boats: PSMA-PET and genomic testing for prostate cancer
4
Armine K. Smith, MD, on addressing sexual health in modern bladder cancer care
5